Clinical Trial Management Systems – Increasing Number of Clinical Trials Leading To the Growth of Clinical Trial Management Systems Market
The Clinical Trial Management System (clinical trial management systems) is an integrated software designed to manage the clinical trial data system used by biotech and pharma companies, it provides customizable functions with advanced technology and tools, which help reduce time and cost during clinical trial by helping to manage large and complex clinical trial data. Also, clinical trial management systems provides various benefits such as easy access to data from various client locations, sharing of information function, data maintenance and security, avoids complexity of administration and helps to manage clinical trials conducted at various locations by providing access to more than one user simultaneously.
According to ClinicalTrials.gov, as of May 2017, 36% clinical trials out of the globe are conducted in United States and 245,188 studies are registered with ClinicalTrials.gov. Furthermore, according to the study conducted by University of Minnesota and University of Michigan by 2018, all the clinical trial conducting company will use OnCore clinical trial management system as OnCore will provide the functional features such as Clinical Research Management, Study Setup, eCRFs, Financials, Visit Tracking & Data Capture, Study Data Management and Revenue Management.
There are two type of clinical trial management systems available and are categorized on the basis of mode of delivery- Cloud based clinical trial management systems and On-premise clinical trial management systems. The Cloud-based/web-based are among the most widely used clinical trial management systems solutions, as it allows for high customization as per requirement, faster turnaround time, and low costs as compared to on-premise clinical trial management systems solutions. Increasing security concerns related to clinical trials data drive companies, especially those focusing on patenting products, also some companies need customization according to their business need, in this cases those companies opt for on-premise clinical trial management systems.
High awareness about the technology for clinical trial management driving the growth of clinical trial management systems market in developed regions
Developed economies such as the U.S., Canada, Germany, Italy, U.K., Australia, Japan and France have well established infrastructure that can support new technologies and being the leading pharmaceutical markets globally, these economies are well backed with funds for improving process efficiencies. As, most major players in the industry are based in North America and Europe they make clinical trial management systems system easily available to clients.
The global clinical trial management systems market was valued at US$ 578.6 million in 2016 and is expected to witness a robust CAGR of 13.0% during the forecast period (2017 – 2025).
Figure: Global Clinical Trial Management System Market, By Region, 2016-2025
Pharmaceuticals manufacturers focusing on achieving first mover advantage is expected to be one of the primary factor for the growth of clinical trial management systems market over the forecast period
The pharmaceuticals sector is highly competitive, with companies vying to achieve first mover advantage, in turn making clinical trials a crucial element. Thus, major players in the market are focusing on integrating clinical trial management systems. The last couple of decades have witnessed robust growth in trade and commerce, with companies across sectors no longer inhibited by physical boundaries. This has enabled companies, including pharmaceuticals manufacturers to tap in to diverse geographical markets in order to increase their consumer base and in turn exponentially increase profits.
The clinical trials helps companies overcome regulatory barriers for drug approval, as they are not restricted to just one market, to conduct trials for rare diseases at diverse locations provides results from humans with different genetic structure, in turn enabling a more complete and effective solution catering to diverse patient population.
Contract research organizations (CROs) in emerging economies expected to fuel the growth in clinical trial management systems market
Emerging economies such as India, Brazil, Argentina, and Iran, still lack adequate infrastructure for clinical trials therefore the outsourcing for clinical trials management systems is preferable way to conduct clinical trials in emerging countries. As companies focus on core aspects such as product development and laying major emphasis on reducing costs, this has led to emergence of various CROs especially in Asia Pacific region.
However, companies, especially in unindustrialized economies are still inclined towards use of rudimentary tools such as spreadsheets for database management, mainly due to lack of awareness about clinical trial management systems and also cost concerns is the growth restraining factor in clinical trial management systems market.
Some of the major companies offering clinical trial management systems are Oracle Corporation, Medidata Clinical Cloud, Veeva Systems, Infosys, Bio-Optronics, BioClinica, and MedNet Solutions.
The software and tools used to manage clinical trials are known as clinical trial management systems (CTMS). CTMS help reduce expenditure of time and money with respect to improved study by providing different benefits such as secure real time access of data from multiple locations. There are two types of CTMS, namely, cloud-based clinical trial management systems and on-premise clinical trial management systems.
Cloud-based CTMS offer 24x7 access, data administration, data security, data access from various client locations, sharing of information and technical support with advanced tools and trained staff. However, on-premise CTMS provides more security of data as it is stored and maintained at on site or at client location. Also, on-premise CTMS provides customization in software as per business needs, control on software upgrades and it is easy to share clinical trials data in house if in case lack of internet connectivity across locations.
As on-premise CTMS needs software to be purchased outright and is relatively capital intensive. However, due to rising data security issue related with cloud-based CTMS, some companies prefer on-premise CTMS.
Increasing number of clinical trials and globalization of R&D is fueling growth of CTMS market, especially in developed regions. Furthermore, rising demand for CTMS to manage multiple and complex data of clinical trials will support the growth of CTMS market in the near future.
The pharmaceuticals sector is highly competitive and companies are focusing on emerging economies to increase consumer base and profit which resulting in increased demand for CTMS, as CTMS helps companies to overcome regulatory barriers for drug approval across the globe. As the cost requirement is relatively very low to conduct clinical trial in emerging markets than developed markets, therefore the companies are focusing on Asia Pacific region which in turn result in high growth of CTMS market in near the future.
Also, companies are approaching to CRO’s as emerging countries lack appropriate infrastructure to conduct clinical trials which, may result in the growth of CTMS market in this region. The North America holds the major market share of CTMS market as the healthcare research organizations and CRO’s in this region are early adopters of CTMS solutions, which is supported by high awareness about CTMS solution among them.
This report segments the global clinical trial management system market on the basis of mode of delivery, offering, end user, and geography. On the basis of mode of delivery, the market is categorized into Cloud-based and On-premise. Among these mode of delivery market cloud-based segment dominate the clinical trial management system market. On the basis of offering, the market is divided into software and services. On the basis of end user, the market is divided into healthcare companies, CRO, medical device companies and others (Research Institutes, Hospitals, etc.). Among all end users, healthcare companies segment dominated the clinical trial management system market, as healthcare companies are highly competitive, vying to achieve first mover advantage.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 35 market data tables and 18 figures on "Clinical Trial management System Market - Global forecast to 2025”.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.